$APDN: Applied DNA Signs Term Sheet with TheraCann International for …

Date: Tuesday, February 12th, 2019

Stock(s) mentioned:

Source: Business Wire (https://www.businesswire.com)

Summary: STONY BROOK, N.Y. & PANAMA CITY–(BUSINESS WIRE)–Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA,” or “the Company”), a leader in …

Full article address: https://www.businesswire.com/news/home/20190212005279/en/Applied-DNA-Signs-Term-Sheet-TheraCann-International

Related News:

$APDN: TheraCann and CannAcubed Enter Collaboration Agreement to …

$APDN: Applied DNA to Webcast 2019 Annual Stockholders’ Meeting

$APDN: Applied DNA Sciences, Inc. (APDN) CEO James Hayward on Q2 …

$APDN: Applied DNA Reports Fiscal Second Quarter 2019 Financial Results

$APDN: A&E to Preview ‘Integrity’ Molecular-Tagged Thread Solution From …

$APDN: Applied DNA’s Molecular Tagging Technology to Ensure …

$APDN: Applied DNA Schedules Fiscal 2019 Second Quarter Financial …

$APDN: LineaRx Achieves Higher Expression and Survival Rates in Human …

$APDN: Applied DNA Receives Initial $1 Million Payment from TheraCann …

$APDN: Applied DNA and GHCL Launch “REKOOP” Verified by the CertainT …

$APDN: Applied DNA Signs Memorandum of Understanding with Process …

Latest News:

$AVTR $FSLY $LK $LYFT $PINS $UBER: Why the IPO Boom Will Continue

$SBUX: Millions of Americans Could Miss Work Tomorrow After the ‘Game of Thrones’ Finale

$AMZN $OXY $APC $WFC $SRE: Want to invest like Warren Buffett? Here are the ins and outs of buying preferred stock

$TSLA $GM: Tesla fires could dampen electric car sales as industry ramps up EV production, auto analysts say

$ROKU $GH $CVNA: 3 Stocks That Have Doubled in 2019 — Are They Still Buys?

$AXSM: Here’s Why You’ll Regret Ignoring This Biotech Stock Rocket

$MMM: Market Loses Its Hopium-Induced High, Falls 4 Weeks Straight

$TLRY $ACB: How Did Tilray Stack Up to the Competition?

$BAH: Booz Allen Has Been a Big Winner, but the Best May Be Yet to Come

$ICPT $GILD: Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences

$JFIN: 3 Reasons iQiyi Held Up Better Than Baidu